Godavari Drugs Ltd

NSE: GODAVARI · BSE: 530317 · Pharmaceuticals & Biotechnology · 19 announcements

Share price: ₹118.10
Market cap: ₹119.6 Cr
Revenue (annual): ₹105.8 Cr
Net profit (annual): ₹4.09 Cr
P/E (TTM): 29.1×Sector 43.8×
Promoter holding: 44.54%+4.31% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Financial Results 1 Debt & Borrowing 1 Convertible Warrants 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 Nov 2026 18:45 IST BSE

Convertible WarrantsAlfa Alert

Godavari Drugs Convertible Warrants

Godavari Drugs allotted 7,86,690 equity shares to promoter-category allottees on conversion of warrants. The balance consideration of Rs 5.25 Crore was received at an issue price of Rs 89.

Value: ₹5.25 Cr

Open announcement → Read the filing ↗